Factor Xa Reactive Antibodies In Patients With Systemic LUPUS Erythematosus and Antiphospholipid Syndrome Have Differential Effects Upon Coagulation Assays and Endothelial CELLS

被引：0
|
作者：
Artim-Esen, Bahar [1 ]
Smoktunowicz, Natalia [1 ]
Pericleous, Charis [1 ]
Ripoll, Vera M. [1 ]
Mackie, Ian [1 ]
Chambers, Rachel [1 ]
Isenberg, David A. [1 ]
Rahman, Anisur [1 ]
Ioannou, Yiannis [1 ]
Giles, Ian [1 ]
机构：
[1] UCL, London, England
来源：
ARTHRITIS AND RHEUMATISM | 2013年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
21
引用
收藏
页码：S9 / S9
页数：1
相关论文
共 50 条
  • [41] ANTIPHOSPHOLIPID ANTIBODIES AND THROMBOSIS IN SYSTEMIC LUPUS-ERYTHEMATOSUS - COMPARISON OF 3 LUPUS ANTICOAGULANT ASSAYS AND ANTICARDIOLIPIN ELISA IN 188 PATIENTS
    JOUHIKAINEN, T
    JULKUNEN, H
    VAARALA, O
    LEIRISALOREPO, M
    STEPHANSSON, E
    VAHTERA, E
    PALOSUO, T
    MYLLYLA, G
    BLOOD COAGULATION & FIBRINOLYSIS, 1992, 3 (04) : 407 - 414
  • [42] Opposite Profiles of Complement in Antiphospholipid Syndrome (APS) and Systemic Lupus Erythematosus (SLE) Among Patients With Antiphospholipid Antibodies (aPL)
    Savelli, Stephanie L.
    Roubey, Robert A. S.
    Kitzmiller, Kathryn J.
    Zhou, Danlei
    Nagaraja, Haikady N.
    Mulvihill, Evan
    Barbar-Smiley, Fatima
    Ardoin, Stacy P.
    Wu, Yee Ling
    Yu, Chack-Yung
    FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [43] ANTIPHOSPHOLIPID ANTIBODIES - A RISK FACTOR FOR OCCLUSIVE OCULAR VASCULAR-DISEASE IN SYSTEMIC LUPUS-ERYTHEMATOSUS AND THE PRIMARY ANTIPHOSPHOLIPID SYNDROME
    ASHERSON, RA
    MERRY, P
    ACHESON, JF
    HARRIS, EN
    HUGHES, GRV
    ANNALS OF THE RHEUMATIC DISEASES, 1989, 48 (05) : 358 - 361
  • [44] The Protective Effects of Statins for Thrombosis in Patients with Systemic Lupus Erythematosus Positive for Antiphospholipid Antibodies.
    Watanabe, Toshiyuki
    Oku, Kenji
    Amengual, Olga
    Sugawara, Eri
    Hisada, Ryo
    Ohmura, Kazumasa
    Fukui, Tomoko
    Shimamura, Sanae
    Nakagawa, Ikuma
    Noguchi, Atsushi
    Shida, Haruki
    Kono, Michihito
    Shimizu, Yuka
    Kurita, Takashi
    Bohgaki, Toshiyuki
    Horita, Tetsuya
    Yasuda, Shinsuke
    Atsumi, Tatsuya
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1154 - S1155
  • [45] Lupus anticoagulant is the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus - Comparison between different assays for the detection of antiphospholipid antibodies
    Horbach, DA
    vanOort, E
    Donders, RCJM
    Derksen, RHWM
    deGroot, PG
    THROMBOSIS AND HAEMOSTASIS, 1996, 76 (06) : 916 - 924
  • [46] INHIBITION OF PROSTACYCLIN RELEASE BY ENDOTHELIAL BINDING ANTICARDIOLIPIN ANTIBODIES IN THROMBOSIS-PRONE PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS AND THE ANTIPHOSPHOLIPID SYNDROME
    LINDSEY, NJ
    HENDERSON, FI
    MALIA, R
    MILFORDWARD, MA
    GREAVES, M
    HUGHES, P
    BRITISH JOURNAL OF RHEUMATOLOGY, 1994, 33 (01): : 20 - 26
  • [47] Antibodies to Domain I β2-Glycoprotein 1 in Patients with Antiphospholipid Syndrome and Systemic Lupus Erythematosus
    T. M. Reshetnyak
    F. A. Cheldieva
    M. V. Cherkasova
    S. I. Glukhova
    A. M. Lila
    E. L. Nasonov
    Doklady Biochemistry and Biophysics, 2023, 511 : 219 - 226
  • [48] Antibodies to Domain I β2-Glycoprotein 1 in Patients with Antiphospholipid Syndrome and Systemic Lupus Erythematosus
    Reshetnyak, T. M.
    Cheldieva, F. A.
    Cherkasova, M. V.
    Glukhova, S. I.
    Lila, A. M.
    Nasonov, E. L.
    DOKLADY BIOCHEMISTRY AND BIOPHYSICS, 2023, 511 (01) : 219 - 226
  • [49] Detection of anti-Annexin IV and V antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus
    Satoh, A
    Suzuki, K
    Takayama, E
    Kojima, K
    Hidaka, T
    Kawakami, M
    Matsumoto, I
    Ohsuzu, F
    JOURNAL OF RHEUMATOLOGY, 1999, 26 (08) : 1715 - 1720
  • [50] The prevalence of antibodies to anionic phospholipids in patients with the primary antiphospholipid syndrome, systemic lupus erythematosus and their relatives and spouses
    Radway-Bright, EL
    Ravirajan, CT
    Isenberg, DA
    RHEUMATOLOGY, 2000, 39 (04) : 427 - 431
12345